Crossmark

Ceftolozane/tazobactam for the treatment of Pseudomonas aeruginosa infections: A multicenter case series analysis

Crossref DOI link: https://doi.org/10.1016/j.eimc.2021.12.008

Published Print: 2023-10

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Leitão, Inês Leonor

Mimoso Santos, Carla

André, Paulo

Lino, Sara

Lemos, Marcos

Froes, Filipe
Funding

Funding for this research was provided by:

Sanofi

Gilead Sciences

Pfizer

AstraZeneca

Meso Scale Diagnostics
License Information

Text and Data Mining valid from 2023-10-01
More Information

This article is maintained by: Elsevier

Article Title: Ceftolozane/tazobactam for the treatment of Pseudomonas aeruginosa infections: A multicenter case series analysis

Journal Title: Enfermedades Infecciosas y Microbiología Clínica

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.eimc.2021.12.008

Content Type: article

Copyright: © 2022 Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. Published by Elsevier España, S.L.U. All rights reserved.